Jakafi 10 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FCMZR
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $39,375
Award facts
- Contract value 100% obligated
- $39,374.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). The delivery order, valued at $39,374.50 with an ultimate completion date of September 9, 2025, represents a single issuance under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA's SPE2DB program. No set-aside designation was utilized for this award, allowing the vendor to compete on open market terms while leveraging its woman-owned small business status. DMS Pharmaceutical Group continues to serve as a critical supplier within the federal pharmaceutical supply chain, distributing prescription medications and medical consumables to Department of Defense healthcare facilities.
This delivery order for Jakafi, a prescription medication used primarily in hematologic malignancy treatment, exemplifies DMS Pharmaceutical Group's established role in supplying specialized pharmaceutical products to military health facilities. The company's $499,999,999 IDC with DLA, valid through November 2026, enables the agency to efficiently procure diverse pharmaceutical inventories across multiple product categories including branded and generic drugs, biologics, and medical consumables. The firm fixed-price structure ensures cost certainty for the government while supporting DLA's mission to maintain adequate medical supply levels across the Department of Defense healthcare system.
Quick answers
Who was awarded contract SPE2DB25FCMZR?
SPE2DB25FCMZR was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 8, 2025.
How much is contract SPE2DB25FCMZR worth?
The government has obligated $39,375 on SPE2DB25FCMZR.
Is contract SPE2DB25FCMZR an order under another contract?
Yes. SPE2DB25FCMZR is a delivery order under SPE2DB24D9144, an indefinite delivery contract.
Was contract SPE2DB25FCMZR competed?
The extent of competition for SPE2DB25FCMZR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award